Modelling of bubble nucleation in trachy-phonolitic magmas: implications for the dynamics of ash-rich eruptions

Nucleation of water gas bubbles in trachyphonolitic magmatic melts has been investigated integrating theory and numerical modelling with decompression experiments and analysis of natural ash samples of explosive eruptions. Bubble nucleation, considered the natural response of magmas to decompression, is strongly dictated by the gas-melt surface tension. Here, I use an integrated approach to quantify the role of the surface tension in the nucleation process combining high pressure - high temperature nucleation experiments with a numerical modelling based on the gradient theory (Cahn and Hilliard, 1959). This theory, successfully applied in several studies of industrial polymers (Poser and Sanchez, 1981; Harrison et al., 1999; Kahl and Enders, 2000; Enders et al., 2005) was never been used before to study systems of volcanological interest. I show that surface tension is far to be a constant, but it decreases with in- creasing nucleation pressure (i.e. the confining pressure). Entering the values of surface tension into the classical theory of nucleation, I obtain a variable supersaturation pressure triggering nucleation. The decreasing value of the gas-melt surface tension with increasing pressure, facilitate bubble nucleation at high pressure, thus enhancing the explosivity of eruptive events from deeper reservoirs. Instead, the hindered nucleation at relatively low pressure, due to high bubble surface tension, implies that the generation of explosive eruptions from shallow reservoirs requires high decompressions. Finally the vesiculation, in terms of nucleation and growth, of natural samples of ash-rich eruptions has been studied by applying a novel technique able to take 3D measurements of bubbles preserved on ash particle’s surface. The Bubble Size Distributions (BSD), together with the field evidence, suggest that the ash production in these ash-rich eruptions, rather than to magma-water explosive interaction, is related to the high decompression necessary to nucleate bubbles in a shallow reservoir

Modelling of bubble nucleation in trachy-phonolitic magmas: implications for the dynamics of ash-rich eruptions

Nucleation of water gas bubbles in trachyphonolitic magmatic melts has been investigated integrating theory and numerical modelling with decompression experiments and analysis of natural ash samples of explosive eruptions. Bubble nucleation, considered the natural response of magmas to decompression, is strongly dictated by the gas-melt surface tension. Here, I use an integrated approach to quantify the role of the surface tension in the nucleation process combining high pressure - high temperature nucleation experiments with a numerical modelling based on the gradient theory (Cahn and Hilliard, 1959). This theory, successfully applied in several studies of industrial polymers (Poser and Sanchez, 1981; Harrison et al., 1999; Kahl and Enders, 2000; Enders et al., 2005) was never been used before to study systems of volcanological interest. I show that surface tension is far to be a constant, but it decreases with in- creasing nucleation pressure (i.e. the confining pressure). Entering the values of surface tension into the classical theory of nucleation, I obtain a variable supersaturation pressure triggering nucleation. The decreasing value of the gas-melt surface tension with increasing pressure, facilitate bubble nucleation at high pressure, thus enhancing the explosivity of eruptive events from deeper reservoirs. Instead, the hindered nucleation at relatively low pressure, due to high bubble surface tension, implies that the generation of explosive eruptions from shallow reservoirs requires high decompressions. Finally the vesiculation, in terms of nucleation and growth, of natural samples of ash-rich eruptions has been studied by applying a novel technique able to take 3D measurements of bubbles preserved on ash particle’s surface. The Bubble Size Distributions (BSD), together with the field evidence, suggest that the ash production in these ash-rich eruptions, rather than to magma-water explosive interaction, is related to the high decompression necessary to nucleate bubbles in a shallow reservoir

Recent increases in winter snowfall provide resilience to very small glaciers in the Julian Alps, Europe

Very small glaciers (<0.5 km2) account for more than 80% of the total number of glaciers and more than 15% of the total glacier area in the European Alps. This study seeks to better understand the impact of extreme snowfall events on the resilience of very small glaciers and ice patches in the southeastern European Alps, an area with the highest mean annual precipitation in the entire Alpine chain. Mean annual precipitation here is up to 3300 mm water equivalent, and the winter snow accumulation is approximately 6.80 m at 1800 m asl averaged over the period 1979–2018. As a consequence, very small glaciers and ice/firn patches are still present in this area at rather low altitudes (1830–2340 m). We performed repeated geodetic mass balance measurements on 14 ice bodies during the period 2006–2018 and the results show an increase greater than 10% increase in ice volume over this period. This is in accordance with several extreme winter snow accumulations in the 2000s, promoting a positive mass balance in the following years. The long-term evolution of these very small glaciers and ice bodies matches well with changes in mean temperature of the ablation season linked to variability of Atlantic Multidecadal Oscillation. Nevertheless, the recent behaviour of such residual ice masses in this area where orographic precipitation represents an important component of weather amplification is somehow different to most of the Alps. We analysed synoptic meteorological conditions leading to the exceptional snowy winters in the 2000s, which appear to be related to the influence and modification of atmospheric planetary waves and Arctic Amplification, with further positive feedbacks due to change in local sea surface temperature and its interactions with low level flows and the orography. Although further summer warming is expected in the next decades, we conclude that modification of storm tracks and more frequent occurrence of extreme snowfall events during winter are crucial in ensuring the resilience of small glacial remnants in maritime alpine sectors

A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation

Nucleotide-binding oligomerization domain leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome is pivotal in maintaining intestinal homeostasis and sustaining enteric immune responses in the setting of inflammatory bowel diseases. Drugs acting as NLRP3 blockers could represent innovative strategies for treatment of bowel inflammation. This study was performed in rats with dinitrobenzenesulfonic acid (DNBS)-induced colitis, to investigate how the direct blockade of NLRP3 inflammasome with an irreversible inhibitor (INF39) compares with Ac-YVAD-cmk (YVAD, caspase-1 inhibitor) and anakinra (IL-1β receptor antagonist), acting downstream on NLRP3 signaling. Animals with DNBS-colitis received YVAD (3 mg/kg) or anakinra (100 mg/Kg) intraperitoneally, and INF39 (25 mg/kg) or dexamethasone (DEX, 1 mg/kg) orally for 6 days, starting on the same day of colitis induction. Under colitis, there was a body weight decrease, which was attenuated by YVAD, anakinra or INF39, but not DEX. All test drugs counteracted the increase in spleen weight. The colonic shortening and morphological colonic alterations associated with colitis were counteracted by INF39, anakinra and DEX, while YVAD was without effects. Tissue increments of myeloperoxidase, tumor necrosis factor and interleukin-1β were more effectively counteracted by INF39 and DEX, than YVAD and anakinra. These findings indicate that: (1) direct inhibition of NLRP3 inflammasome with INF39 is more effective than caspase-1 inhibition or IL-1β receptor blockade in reducing systemic and bowel inflammatory alterations; (2) direct NLRP3 inhibition can be a suitable strategy for treatment of bowel inflammation

Maqui and Omega 3: effects on lipid profile, oxidative stress levels and psycho-physical items in human subjects

Aims: to assess short-term efficacy of supplementation with Maqui (Aristotelia Chilensis (Mol.Stuntz)), a polyphenol with antioxidant power, and EPA/DHA concerning metabolism, oxidative stress and mental/physical state. Patients and Methods: a pilot prospective observational clinical/laboratory study was performed on 17 apparently healthy subjects (8 males and 9 females, mean age 47 years). All subjects received for two months: a) Maqui 600 mg per day and b) 360 mg of EPA and 240 mg of DHA (salmon oil) daily. At day 0 and day 60 all subjects underwent nine laboratory tests related to inflammation, metabolism (lipid profile mainly) and oxidative stress parameters. Pre-post treatment weight and BMI was calculated. A few physical and mental parameters were assessed by means of Short-Form 12 questionnaire. Statistical analysis was applied to the resulting data through Wilcoxon test and t-paired test. Results: laboratory results before and after Maqui + EPA/DHA supplementation were respectively (mean and p-value for the comparison): total cholesterol 228.8/199.8 mg/dl, p=0.23; low density lipoproteins 127.4/122.1 mg/dl, p=0.13; high density lipoproteins 59.1/57.6 mg/dl, p=0.25; Reactive C Protein 0.18/0.09 mg/dl, p=0.32; triglycerides 106.1/91.1 mg/dl p=0.09, glycemia 92.9/92.8 mg/dl p= 0.92; total free radicals 338.0/303.6 U.Carr., p=0.002; serum anti-oxidant capacity 2075/2190 umol/l, p= 0.04; oxidized lipoproteins 641.8/553.1 uEq/l, p=0.10. SF12 physical and mental items (mean values and SD) were 51.2 (+/- 6.2) and 41.2 (+/- 3,3) at day 0 and 54.6 (+/- 11.6) and 47.2 (+/- 9.7) at day 60 respectively. One case of transient constipation was recorded. Conclusions: daily supplementation with Maqui 600 mg + Omega 3 fatty acids (EPA 360 mg + DHA 240 mg) in apparently healthy middle-aged subjects resulted in a statistically significant improvement of oxidative stress parameters. An overall (non statistically significant) improvement of dysmetabolism biomarkers was achieved. Mental and physical parameters have mildly improved

Analytical development to support manufacturing of a sustainable vaccine against Invasive Nontyphoidal Salmonellosis

GVGH is developing a candidate trivalent Salmonella vaccine to fight invasive nontyphoidal Salmonellosis (iNTS) and typhoid fever, especially aimed for sub-Saharan Africa to impact disease burden and to reduce anti-microbial resistance spread. This trivalent vaccine may be the only viable option for a sustainable iNTS vaccine in sub-Saharan Africa over the separate administration of Typhoid Conjugate Vaccines (TCV) and a vaccine against iNTS. GVGH generated the iNTS-TCV formulation by combining the GMMA technology for the iNTS components, S. Typhimurium (STm) and S. Enteritidis (SEn) GMMA adsorbed on Alhydrogel, and the Vi-CRM197 glycoconjugate, originally developed by GVGH and recently WHO prequalified as TCV TYPHIBEV by Biological E Ltd (Hyderabad, India). A set of analytical methods to support the vaccine lot release and characterization have been developed by GVGH. In particular, to quantify the key active ingredients of iNTS components a competitive ELISA-based method (FAcE, Formulated Alhydrogel competitive ELISA assay) has been setup and characterized in terms of specificity, accuracy and precision. Vi component is instead characterized by means of HPAEC-PAD method, able to specifically identify and quantify the total polysaccharide in the final drug product. With regard to safety assessment, a Monocyte Activation Test (MAT) has been developed as to monitor the intrinsic pyrogenicity of GMMA-based vaccines and applied as surveillance test for the Phase 1 clinical lot, with the plan to set release criteria based on clinical experience. In vivo potency assay has been set to characterize the immunogenicity of vaccine lots in comparison to freshly formulated material at the time of release and during real-time stability. A significant antibody response to each of the active ingredients of the trivalent vaccine is raised in mice and assessed by Parallel Line Assay. Overall, the applied analytical panel and the results support the development of an iNTS-TCV vaccine as a viable option for a sustainable iNTS vaccine in sub-Saharan Africa